Hemoglobin, nitric oxide and molecular mechanisms of hypoxic vasodilation

Trends in Molecular Medicine

Volumn 15, Issue 10, 2009, Pages 452-460

  Allen, Barry W ^a   Stamler, Jonathan S ^a   Piantadosi, Claude A ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE; HEMOGLOBIN; HEMOGLOBIN BETA CHAIN; HEMOGLOBIN DERIVATIVE; NITRIC OXIDE; NITRITE; S NITROSOHEMOGLOBIN; S NITROSOTHIOL; UNCLASSIFIED DRUG;

ALLOSTERISM; COVALENT BOND; ERYTHROCYTE MEMBRANE; HUMAN; HYPOXIA; MEMBRANE TRANSPORT; MICROCIRCULATION; NITROSATION; NITROSYLATION; NONHUMAN; OXYGEN SATURATION; PATHOPHYSIOLOGY; PERFUSION; REVIEW; VASCULAR ENDOTHELIUM; VASODILATATION;

ANIMALS; CELL HYPOXIA; ENDOTHELIUM, VASCULAR; HEMOGLOBINS; HUMANS; NITRIC OXIDE; NITROSATION; OXYGEN; S-NITROSOTHIOLS; VASODILATION;

EID: 70350005373     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molmed.2009.08.002     Document Type: Review

References (98)

1. Zelis R., and Mason D.T. Mechanism of systemic hemodynamic response during limb reactive hyperemia. Am J Physiol 217 (1969) 1742-1746
2. Crawford D.G., et al. Oxygen lack as a possible cause of reactive hyperemia. Am J Physiol 197 (1959) 613-616
3. Gladwin M.T. Evidence mounts that nitrite contributes to hypoxic vasodilation in the human circulation. Circulation 117 (2008) 594-597
4. Maher A.R., et al. Hypoxic modulation of exogenous nitrite-induced vasodilation in humans. Circulation 117 (2008) 670-677
5. Hunter C.J., et al. Inhaled nebulized nitrite is a hypoxia-sensitive NO-dependent selective pulmonary vasodilator. Nat Med 10 (2004) 1122-1127
6. Isbell T.S., et al. SNO-hemoglobin is not essential for red blood cell-dependent hypoxic vasodilation. Nat Med 14 (2008) 773-777
7. Weir E.K., and Archer S.L. The mechanism of acute hypoxic pulmonary vasoconstriction: the tale of two channels. FASEB J. 9 (1995) 183-189
8. Deem S., et al. Pulmonary vascular effects of red blood cells containing S-nitrosated hemoglobin. Am J Physiol Heart Circ Physiol 287 (2004) H2561-2568
9. Xu X., et al. Measurements of nitric oxide on the heme iron and β93 thiol of human hemoglobin during cycles of oxygenation and deoxygenation. PNAS 100 (2003) 11303-11308
10. Gladwin M.T., et al. Relative role of heme nitrosylation and β-cysteine 93 nitrosation in the transport and metabolism of nitric oxide by hemoglobin in the human circulation. PNAS 97 (2000) 9943-9948
11. Cosby K., et al. Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation. Nature Medicine 9 (2003) 1498-1505
12. Crawford J.H., et al. Hypoxia, red blood cells, and nitrite regulate NO-dependent hypoxic vasodilation. Blood 107 (2006) 566-574
13. Hausladen A., et al. Assessment of nitric oxide signals by triiodide chemiluminescence. PNAS 104 (2007) 2157-2162
14. Stamler J.S. S-nitrosothiols in the blood: Roles, amounts and methods of analysis. Circulation Research 94 (2004) 414-417
15. 2 gradients. PNAS 102 (2005) 5709-5714
16. Cha W., et al. Amperometric S-nitrosothiol sensor with enhanced sensitivity based on organoselenium catalysts. Biosensors and Bioelectronics 24 (2009) 2441-2446
17. Jia H.Y., et al. Potential oxidative stress of gold nanoparticles by induced-NO releasing in serum. Journal of the American Chemical Society 131 (2009) 40-41
18. Bramanti E., et al. Determination of S-nitrosoglutathione and other nitrosothiols by p-hydroxymercurybenzoate derivatization and reverse phase chromatography coupled with chemical vapor generation atomic fluorescence detection. Talanta 77 (2008) 684-694
19. Allen B.W., and Piantadosi C.A. How do red blood cells cause hypoxic vasodilation? The SNO-hemoglobin paradigm. Am. J. Physiol. Heart. Circ. Physiol. 291 (2006) H1507-H1512
20. Ross J.M., et al. Autoregulation of blood flow by oxygen lack. Am. J. Physiol. 202 (1962) 21-24
21. Jia L., et al. S-nitrosohemoglobin: a dynamic activity of blood involved in vascular control. Nature 380 (1996) 221-226
22. Stamler J.S., et al. Blood flow regulation by S-nitrosohemoglobin in the physiological oxygen gradient. Science 276 (1997) 2034-2037
23. Noble D.R., et al. Nitric oxide release from S-nitrosoglutathione (GSNO). Chem. Commun. (1999) 2317-2318
24. Myers P.R., et al. Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrosocysteine than nitric oxide. Nature 345 (1990) 161-163
25. Webb A.J., et al. Mechanisms underlying erythrocyte and endothelial nitrite reduction to nitric oxide in hypoxia. Role for xanthine oxidoreductase and endothelial nitric oxide synthase. Circ. Res. 108 (2008) 175810
26. Reiter C.D., et al. Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nature Medicine 8 (2002) 1383-1389
27. Wiley K.E., and Davenport A.P. Comparison of vasodilators in human internal mammary artery: ghrelin is a potent physiological antagonist of endothelin-1. Br J Pharmacol 136 (2002) 1146-1152
28. Ellsworth M.L., et al. The erythrocyte as a regulator of vascular tone. Am J Physiol Heart Circ Physiol 269 (1995) H2155-2161
29. Gonzalez-Alonso J., et al. Erythrocyte and the regulation of human skeletal muscle blood flow and oxygen delivery: role of circulating ATP. Circ Res 91 (2002) 1046-1055
30. 1 receptors mediate endothelial dependent vasodilation to ATP. Mol Pharmacol 72 (2007) 1132-1136
31. Lange T., et al. Reduced number of CFTR molecules in erythrocyte plasma membrane of cystic fibrosis patients. Molecular Membrane Biology 23 (2006) 317-323
32. Segal S.S. Regulation of blood flow in the microcirculation. Microcirculation 12 (2005) 33-45
33. Martinez-Lemus L.A., et al. The plastic nature of the vascular wall: a continuum of remodeling events contributing to control of arteriolar diameter and structure. Physiology 24 (2009) 45-57
34. Stamler J.S., et al. Biochemistry of nitric oxide and its redox-activated forms. Science 258 (1992) 1898-1902
35. Sandmann J., et al. Specific transport of S-nitrosocysteine in human red blood cells: implications for formation of S-nitrosothiols and transport of NO bioactivity within the vasculature. FEBS Letters 579 (2005) 4119-4124
36. Angelo M., et al. An S-nitrosothiol (SNO) synthase function of hemoglobin that utilizes nitrite as a substrate. PNAS 103 (2006) 8366-8371
37. Gow A., et al. S-nitrosothiol measurements in biological systems. Journal of Chromatography B 851 (2007) 140-151
38. Tsoukias N.M. Nitric oxide bioavailability in the microcirculation: Insights from mathematical models. Microcirculation 15 (2008) 813-834
39. Bonaventura J., and Lance V.P. Nitric oxide, invertebrates and hemoglobin. Amer. Zool. 41 (2001) 346-359
40. Li S., and Whorton A.R. Identification of stereoselective transporters for S-nitroso-l-cysteine: role of LAT1 and LAT2 in biological activity of S-nitrosothiols. J. Biol. Chem. 280 (2005) 20102-20110
41. Bolotina V.M., et al. Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature 368 (1994) 850-853
42. Liu Z., et al. S-transnitrosation reactions are involved in the metabolic fate and biological actions of nitric oxide. J Pharmacol Exp Ther 284 (1998) 526-534
43. McMahon T.J., et al. Functional coupling of oxygen binding and vasoactivity in S-nitrosohemoglobin. J. Biol. Chem. 275 (2000) 16738-16745
44. Tsikas D., et al. Investigations of S-transnitrosylation reactions between low and high molecular weight S-nitroso compounds and their thiols by high-performance liquid chromatography and gas chromatography-mass spectrometry. Analytical Biochemistry 270 (1999) 231-241
45. Diesen D.L., et al. Hypoxic vasodilation by red blood cells: evidence for an S-nitrosothiol based signal. Circulation Research 103 (2008) 545-553
46. Dalsgaard T., et al. Nitrite-dependent vasodilation is facilitated by hypoxia and is independent of known NO-generating nitrite reductase activities. Am J Physiol Heart Circ Physiol (2007) 01298.02006
47. Lauer T., et al. Plasma nitrite rather than nitrate reflects regional endothelial nitric oxide synthase activity but lacks intrinsic vasodilator action. Proc Natl Acad Sci 98 (2001) 2814-12819
48. Gladwin M.T., and Schechter A.N. NO contest: nitrite versus S-nitrosohemoglobin. Circ Res 94 (2004) 851-855
49. van Faassen E.E., et al. Nitrite as regulator of hypoxic signaling in mammalian physiology. Medicinal Research Reviews 29 (2009) 683-741
50. Singel D.J., and Stamler J.S. Chemical physiology of blood flow regulation by red blood cells. Annual Review of Physiology 67 (2005) 99-145
51. Foster M.W., et al. A genetic analysis of nitrosative stress. Biochemistry 48 (2009) 792-799
52. Pawloski J.R., et al. Impaired vasodilation by red blood cells in sickle-cell disease. PNAS 102 (2005) 2531-2536
53. Liu L., et al. Essential roles of S-nitrosothiols in vascular homeostasis and endotoxic shock. Cell 116 (2004) 617-628
54. Lima B., et al. Endogenous S-nitrosothiols protect against myocardial injury. PNAS 106 (2009) 6297-6302
55. Palmer L.A., et al. S-nitrosothiols signal hypoxia-mimetic vascular pathology. J. Clin. Invest. 117 (2007) 2592-2601
56. 2 content and tension in regulation of cardiac output and leg blood flow during exercise in humans. Am J Physiol Heart Circ Physiol 276 (1999) H438-445
57. McMahon T.J., et al. A nitric oxide processing defect of red blood cells created by hypoxia: deficiency of S-nitrosohemoglobin in pulmonary hypertension. PNAS 102 (2005) 14801-14806
58. Stamler J.S., et al. SNO-hemoglobin and hypoxic vasodilation. Nat Med 14 (2008) 1008-1009
59. Chen Z., and Stamler J.S. Bioactivation of nitroglycerin by the mitochondrial aldehyde dehydrogenase. Trends in Cardiovascular Medicine 16 (2006) 259-265
60. Lauer T., et al. Indexes of NO bioavailability in human blood. News Physiol Sci 17 (2002) 251-255
61. Shah C.M., et al. Interactions between cell surface protein disulphide isomerase and S-nitrosoglutathione during nitric oxide delivery. Nitric Oxide 16 (2007) 135-142
62. Ellgaard L., and Ruddock L.W. The human protein disulphide isomerase family: substrate interactions and functional properties. EMBO reports 6 (2005) 28-32
63. Huang A., et al. Contrasting effects of thiol-modulating agents on endothelial NO bioactivity. Am J Physiol Cell Physiol 281 (2001) C719-725
64. Pawloski J.R., et al. Export by red blood cells of nitric oxide bioactivity. Nature 409 (2001) 622-626
65. Walsh S., et al. Cation transport activity of Anion Exchanger 1 mutations found in inherited distal renal tubular acidosis. Am J Physiol Renal Physiol 295 (2008) F343-350
66. Köck K., et al. Expression of adenosine triphosphate-binding cassette (ABC) drug transporters in peripheral blood cells: relevance for physiology and pharmacotherapy. Clinical Pharmacokinetics 46 (2007) 449-470
67. Ignarro L.J., and Gruetter C.S. Requirement of thiols for activation of coronary arterial guanylate cyclase by glyceryl trinitrate and sodium nitrite: possible involvement of S-nitrosothiols. Biochimica et Biophysica Acta (BBA) - General Subjects 631 (1980) 221-231
68. Carlsen E., and Comroe Jr. J.H. The rate of uptake of carbon monoxide and of nitric oxide by normal human erythrocytes and experimentally produced spherocytes. J. Gen. Physiol. 42 (1958) 83-107
69. Gibson Q.H., and Roughton F.J.W. The kinetics and equilibria of the reaction of nitric oxide with sheep hemoglobin. Journal of Physiology 136 (1957) 507-526
70. Joshi M.S., et al. Nitric oxide is consumed, rather than conserved, by reaction with oxyhemoglobin under physiological conditions. PNAS 99 (2002) 10341-10346
71. Gladwin M.T., et al. Inhaled nitric oxide augments nitric oxide transport on sickle-cell hemoglobin without affecting oxygen affinity. J. Clin. Invest. 104 (1999) 937-945
72. Gladwin M.T., et al. Role of circulating nitrite and S-nitrosohemoglobin in the regulation of regional blood flow in humans. PNAS 97 (2000) 11482-11487
73. Nagababu E., et al. Active nitric oxide produced in the red cell under hypoxic conditions by deoxyhemoglobin-mediated nitrite reduction. J. Biol. Chem. 278 (2003) 46349-46356
74. Lundberg J.O., and Weitzberg E. NO generation from nitrite and its role in vascular control. Arterioscler Thromb Vasc Biol 25 (2005) 915-922
75. Modin A., et al. Nitrite-derived nitric oxide: a possible mediator of 'acidic-metabolic' vasodilation. Acta Physiologica Scandinavica 171 (2001) 9-16
76. Cannon R.O., et al. Effects of inhaled nitric oxide on regional blood flow are consistent with intravascular nitric oxide delivery. J. Clin. Invest. 108 (2001) 279-287
77. Dejam A., et al. Nitrite infusion in humans and nonhuman primates: Endocrine effects, pharmacokinetics and tolerance formation. Circulation 116 (2007) 1821-1831
78. Ng E.S.M., et al. Enhanced S-nitroso-albumin formation from inhaled NO during ischemia/reperfusion. Circ Res 94 (2004) 559-565
79. Doyle M., et al. Kinetics and mechanism of the oxidation of human deoxyhemoglobin by nitrites. J. Biol. Chem. 256 (1981) 12393-12398
80. Isbell T.S., et al. Hemoglobin oxygen fractional saturation regulates nitrite-dependent vasodilation of aortic ring bioassays. Am J Physiol Heart Circ Physiol 293 (2007) H2565-2572
81. Kleinbongard P., et al. Plasma nitrite reflects constitutive nitric oxide synthase activity in mammals. Free Radical Biology and Medicine 35 (2003) 790-796
82. Honig C.R., et al. Capillary recruitment in exercise: rate, extent, uniformity and relation to blood flow. Am J Physiol Heart Circ Physiol 238 (1980) H31-42
83. Tu C., et al. Reactions of nitrite with hemoglobin measured by membrane inlet mass spectrometry. Free Radical Biology and Medicine 46 (2009) 14-19
84. Luchsinger B.P., et al. Routes to S-nitroso-hemoglobin formation with heme redox and preferential reactivity in the beta subunits. PNAS 100 (2003) 461-466
85. McMahon T.J., et al. Nitric oxide in the human respiratory cycle. Nature Medicine 8 (2002) 711-717
86. Auten R.L., et al. Inhaled ethyl nitrite prevents hyperoxia-impaired postnatal alveolar development in newborn rats. Am. J. Respir. Crit. Care Med. 176 (2007) 291-299
87. Moya M.P., et al. Inhaled ethyl nitrite gas for persistent pulmonary hypertension of the newborn. The Lancet 360 (2002) 141-143
88. NIH. Clinical trial (NCT00787124): transfusions and nitric oxide level in preterm infants (2009), PB Smith, principal investigator
89. James P.E., et al. Vasorelaxation by red blood cells and impairment in diabetes: reduced nitric oxide and oxygen delivery by glycated hemoglobin. Circ Res 94 (2004) 976-983
90. 0 and hemoglobin S: Implications for interactions of nitric oxide with normal and sickle red blood cells. J. Biol. Chem. 277 (2002) 14557-14563
91. Datta B., et al. Red blood cell nitric oxide as an endocrine vasoregulator: a potential role in congestive heart failure. Circulation 109 (2004) 1339-1342
92. Crawford J.H., et al. Transduction of NO-bioactivity by the red blood cell in sepsis: novel mechanisms of vasodilation during acute inflammatory disease. Blood 104 (2004) 1375-1382
93. Gandley R.E., et al. S-nitroso-albumin-mediated relaxation is enhanced by ascorbate and copper: effects in pregnancy and preeclampsia plasma. Hypertension 45 (2005) 21-27
94. Cho D.-H., et al. S-nitrosylation of Drp1 mediates β-amyloid-related mitochondrial fission and neuronal injury. Science 324 (2009) 102-105
95. Bennett-Guerrero E., et al. Evolution of adverse changes in stored RBCs. PNAS 104 (2007) 17063-17068
96. Reynolds J.D., et al. S-nitrosohemoglobin deficiency: a mechanism for loss of physiological activity in banked blood. PNAS 104 (2007) 17058-17062
97. Stamler J.S., et al. Nitrosylation: the prototypic redox-based signaling mechanism. Cell 106 (2001) 675-683
98. Foster M.W., et al. Protein S-nitrosylation in health and disease: A current perspective. Trends in Molecular Medicine 15 (2009) 391-404